[Prevention of carcinogenesis in familial tumors]

Hideki Ishikawa1

  • 1Dept. of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Osaka, Japan.

Insights

Preventing familial colorectal cancer (CRC) is challenging. While non-steroidal anti-inflammatory drugs (NSAIDs) like sulindac show polyp reduction, side effects limit use. Newer COX-2 inhibitors and dietary components are under investigation for safer, effective familial CRC prevention.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pharmacology

Context:

  • Familial colorectal cancer (CRC) encompasses hereditary conditions like familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC).
  • Effective cancer prevention strategies for hereditary CRC syndromes are crucial due to increased cancer risk.
  • Current prevention research focuses on pharmacological and dietary interventions.

Purpose:

  • To review the current state of the art in cancer prevention for familial colorectal cancer.
  • To evaluate the efficacy and safety of interventions, including non-steroidal anti-inflammatory drugs (NSAIDs) and dietary components.
  • To identify promising future directions in familial CRC prevention.

Summary:

  • Sulindac, a non-steroidal anti-inflammatory drug (NSAID), has been extensively studied for familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC), demonstrating a reduction in polyp size and number.
  • Despite efficacy, sulindac's clinical use is restricted by significant gastrointestinal side effects and instances of aggressive tumor development.
  • Selective COX-2 inhibitors show promise for reduced gastrointestinal toxicity.
  • Vitamins and dietary components have been explored, exhibiting minimal side effects but insufficient efficacy, necessitating further research.

Impact:

  • Identifies limitations of current NSAID-based strategies for familial colorectal cancer prevention.
  • Highlights the potential of selective COX-2 inhibitors as a safer alternative.
  • Underscores the need for continued research into dietary interventions for improved efficacy and safety in hereditary cancer syndromes.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...